A detailed history of Allstate Corp transactions in Bio Techne Corp stock. As of the latest transaction made, Allstate Corp holds 4,639 shares of TECH stock, worth $297,916. This represents 0.01% of its overall portfolio holdings.

Number of Shares
4,639
Holding current value
$297,916
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

BUY
$66.37 - $78.17 $307,890 - $362,630
4,639 New
4,639 $334,000
Q4 2022

Feb 14, 2023

BUY
$80.67 - $352.29 $482,648 - $2.11 Million
5,983 Added 318.75%
7,860 $651,000
Q3 2022

Nov 14, 2022

BUY
$282.54 - $391.85 $54,530 - $75,627
193 Added 11.46%
1,877 $533,000
Q2 2022

Aug 15, 2022

BUY
$322.67 - $449.65 $543,376 - $757,210
1,684 New
1,684 $584,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.52B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Allstate Corp Portfolio

Follow Allstate Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allstate Corp, based on Form 13F filings with the SEC.

News

Stay updated on Allstate Corp with notifications on news.